Integrated ReportFiscal Year Ended Mar. 31, 2021
Our Company
Our Strategy
- Sustainability
- Four Key Components of Our Corporate Strategy
- Message from the COO
- Medical Business Strategy: Chinese Market
- Medical Business Strategy: Strengthening Business Foundations and Corporate Portfolio
- Reprocessing
- Endoscopic Solutions Division
- Therapeutic Solutions Division
- Scientific Solutions Division
- Message from the CTO
- EVIS X1 Dialogue
- Innovation Initiatives
- Message from the CAO
- Overview of Transform Olympus
- Evolving Our Corporate Culture
Our Setup
- Directors
- Governance Roundtable Discussion
- Corporate Governance
- Risk Management
- Information Security
- Information Disclosure
Data
- Global Healthcare Data
- 10-Year Financial/Non-financial Data
- Overview of Operating Results and Others
- Consolidated Financial Statements and Notes
- Independent Auditor’s Report
- Corporate Information/Stock Information